Literature DB >> 34632487

Normal values and reference ranges for left atrial strain by speckle-tracking echocardiography: the Copenhagen City Heart Study.

Anne Bjerg Nielsen1,2, Kristoffer Grundtvig Skaarup1,2, Raphael Hauser1,2, Niklas Dyrby Johansen1,2, Mats Christian Højbjerg Lassen1,2, Gorm Boje Jensen2, Peter Schnohr2, Rasmus Møgelvang2,3, Tor Biering-Sørensen1,4.   

Abstract

AIMS: Left atrial (LA) function assessed by two-dimensional speckle-tracking echocardiography has shown increasing clinical and prognostic significance. We sought to establish age- and sex-based normative values of LA strain in the general population and to assess the prognostic yield of lower limits of normality of LA strain in relation to future atrial fibrillation (AF). METHODS AND
RESULTS: We determined normative values of peak atrial longitudinal strain (PALS), peak atrial contraction strain (PACS), and LA strain during the conduit phase (LACS) in 1641 healthy participants included in the fifth Copenhagen City Heart Study. In a secondary analysis, a validation cohort of 2016 participants, regardless of health status, were included to assess the prognostic value of the established reference values. In the healthy cohort, median age was 46 years (interquartile range 32-57), 62% were female. Median PALS, PACS, and LACS and corresponding limits of normality in the healthy participants were 39.4% (23.0-67.6%), 15.5% (6.4-28.0%), and 23.7% (8.8-44.8%), respectively. There was a tendency of lower values of PALS and LACS in males and older participants, while PACS tended to increase with advancing age. The established lower limits of normality showed high specificity (range 93-94%) regarding future AF, implying a low risk of developing AF in participants with LA strain above the lower limits of normality in their respective sex and age group.
CONCLUSION: We report normal values for LA strain stratified by sex and age. The lower limits of normality showed high specificity regarding future AF. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  2D speckle-tracking echocardiography; atrial fibrillation; general population; left atrial function; left atrial strain; normative values

Mesh:

Year:  2021        PMID: 34632487     DOI: 10.1093/ehjci/jeab201

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  4 in total

Review 1.  Cardiac Imaging for the Assessment of Left Atrial Mechanics Across Heart Failure Stages.

Authors:  Francesco Bandera; Anita Mollo; Matteo Frigelli; Giulia Guglielmi; Nicoletta Ventrella; Maria Concetta Pastore; Matteo Cameli; Marco Guazzi
Journal:  Front Cardiovasc Med       Date:  2022-01-13

2.  Exercise-Induced Atrial Remodeling in Female Amateur Marathon Runners Assessed by Three-Dimensional and Speckle Tracking Echocardiography.

Authors:  Zofia Lasocka; Zuzanna Lewicka-Potocka; Anna Faran; Ludmiła Daniłowicz-Szymanowicz; Radosław Nowak; Damian Kaufmann; Anna Kaleta-Duss; Leszek Kalinowski; Grzegorz Raczak; Ewa Lewicka; Alicja Dąbrowska-Kugacka
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

3.  Potential role of conventional and speckle-tracking echocardiography in the screening of structural and functional cardiac abnormalities in elderly individuals: Baseline echocardiographic findings from the LOOP study.

Authors:  Flemming Javier Olsen; Søren Zöga Diederichsen; Peter Godsk Jørgensen; Magnus T Jensen; Anders Dahl; Nino Emmanuel Landler; Claus Graff; Axel Brandes; Derk Krieger; Ketil Haugan; Lars Køber; Søren Højberg; Jesper Hastrup Svendsen; Tor Biering-Sørensen
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

4.  Left atrial strain imaging: ready for clinical implementation in heart failure with preserved ejection fraction.

Authors:  Espen Boe; Otto A Smiseth
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-08-22       Impact factor: 9.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.